Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?
暂无分享,去创建一个
C. O'connor | M. Vaduganathan | J. Butler | G. Fonarow | M. Jessup | J. Lindenfeld | M. Fiuzat | O. Vardeny | S. Greene | A. Tahhan | Alaaeddin Alrohaibani
[1] C. O'connor,et al. Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review , 2018, JAMA cardiology.
[2] Francesca N. Delling,et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.
[3] I. Piña,et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.
[4] Harlan M Krumholz,et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. , 2011, JAMA.
[5] James Brian Byrd,et al. Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema , 2010, Pharmacogenetics and genomics.